More than a decade ago, scientists around the world confidently predicted that stem cell research would revolutionise medicine. Enabling legislation followed the technology, as did a dramatic increase in funding that paralleled the public’s impatient expectations. It’s only within the past couple of years that we have finally started to see the vanguard of this regenerative movement begin to be realised – what began as a trickle of clinical trials has now become a steady stream around the globe.

Harriet Manley, a 22 year old PhD student working at ARMI, is investigating neutrophils in zebrafish to see what makes cells motile as she believes this will help us better understand the immune response. It may also reveal clues as to how cancer cells gain motility and spread through our body.